City of Baltimore awarded $475K in opioids-related pharmaceutical settlement

The City of Baltimore on Wednesday received nearly $475,000 from a settlement involving Mallinckrodt Pharmaceuticals, which filed for bankruptcy in October 2020 to resolve widespread litigation brought by states, local governments and private individuals accusing it of deceptive marketing practices with respect to the sale of its opioids, including downplaying the risks of addiction and abuse.